A detailed history of Janiczek Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 620 shares of AMGN stock, worth $195,634. This represents 0.04% of its overall portfolio holdings.

Number of Shares
620
Previous 727 14.72%
Holding current value
$195,634
Previous $206,000 6.31%
% of portfolio
0.04%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$262.75 - $319.31 $28,114 - $34,166
-107 Reduced 14.72%
620 $193,000
Q1 2024

Apr 15, 2024

SELL
$268.87 - $324.56 $8,066 - $9,736
-30 Reduced 3.96%
727 $206,000
Q4 2023

Jan 26, 2024

BUY
$255.7 - $288.46 $15,597 - $17,596
61 Added 8.76%
757 $218,000
Q3 2023

Oct 13, 2023

BUY
$218.65 - $271.46 $82,431 - $102,340
377 Added 118.18%
696 $187,000
Q2 2023

Jul 11, 2023

SELL
$214.27 - $253.37 $22,069 - $26,097
-103 Reduced 24.41%
319 $70,000
Q1 2023

Apr 21, 2023

BUY
$225.79 - $275.2 $26,643 - $32,473
118 Added 38.82%
422 $102,000
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $17,635 - $22,407
77 Added 33.92%
304 $0
Q3 2022

Oct 17, 2022

SELL
$224.46 - $253.15 $48,932 - $55,186
-218 Reduced 48.99%
227 $53,000
Q2 2022

Aug 03, 2022

SELL
$230.71 - $256.74 $8,305 - $9,242
-36 Reduced 7.48%
445 $110,000
Q1 2022

May 05, 2022

BUY
$219.27 - $242.57 $53,282 - $58,944
243 Added 102.1%
481 $117,000
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $39,974 - $45,747
-201 Reduced 45.79%
238 $54,000
Q3 2021

Oct 19, 2021

SELL
$212.27 - $248.7 $1,061 - $1,243
-5 Reduced 1.13%
439 $93,000
Q2 2021

Jul 28, 2021

SELL
$233.58 - $259.14 $5,605 - $6,219
-24 Reduced 5.13%
444 $108,000
Q1 2021

Apr 28, 2021

BUY
$221.91 - $258.6 $37,280 - $43,444
168 Added 56.0%
468 $116,000
Q4 2020

Jan 26, 2021

BUY
$216.38 - $257.67 $51,065 - $60,810
236 Added 368.75%
300 $69,000
Q3 2020

Oct 19, 2020

BUY
$234.65 - $260.95 $15,017 - $16,700
64 New
64 $16,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.